Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SNCG (Breast Cancer-Specific Protein 1) antibody

Reactivity: Human IHC, ELISA, WB Monoclonal unconjugated
Catalog No. ABIN967062
  • Target
    SNCG (Breast Cancer-Specific Protein 1)
    Reactivity
    Human
    Host
    Please inquire
    Clonality
    • 1
    Monoclonal
    Conjugate
    • 1
    Un-conjugated
    Application
    Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
    Specificity
    Ni-NTA purified truncated recombinant SNCG expressed in E. Coli strain BL21 (DE3)
    Purification
    Antibodies are purified by protein A affinity chromatography
    Isotype
    IgG1
  • Application Notes
    Western Blot: 1: 500- 1: 2,000
    IHC(P): 1: 500- 1: 2,000
    IHC(F): 1: 500- 1: 2,000
    ELISA: Propose dilution 1: 10,000.
    Determining optimal working dilutions by titration test.
    Restrictions
    For Research Use only
  • Storage
    -20 °C
  • Surgucheva, McMahon, Surguchov: "gamma-synuclein has a dynamic intracellular localization." in: Cell motility and the cytoskeleton, Vol. 63, Issue 8, pp. 447-58, (2006) (PubMed).

  • Target
    SNCG (Breast Cancer-Specific Protein 1)
    Background
    SNCG(also designated gamma-synuclein or breast cancer-specific protein 1),with 127-amino acid protein(about 14kDa), belongs to the synuclein family, which also includes alpha- and beta- synuclein. Three synucleins are located in the neuronal cytosol and enriched in presynaptic terminals,while SNCG is also expressed in many other non-neuronal tissues. SNCG is abnormally expressed in a high percentage of tumor tissues of diversified cancer types, including liver, esophagus, colon, gastric, lung, prostate, cervical, and breast cancer, but rarely expressed in tumor-matched nonneoplastic adjacent tissues. High levels of SNCG have been identified in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development.
    Gene ID
    6623
You are here:
Support